Updated Jul 16, 2026
KAVANAGH SARAH B has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Sarah B. Kavanagh is listed as a director of Bausch Health Companies Inc. in SEC filings as of May 26, 2026. Publicly available information within the SEC context is limited to her board role; there is no readily accessible detailed biography within the provided context. There is no evidence in the available data that she has passed away as of the filing date.
| Role | Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-28 | BLCO | Bausch & Lomb Corp | A — Grant or award | 15.8K | $15.78 | $250K |
| 2026-05-26 | BHC | Bausch Health Companies Inc. | A — Grant or award | 45.9K | $0.00 |
Sarah B. Kavanagh is listed as a director of Bausch Health Companies Inc. in SEC filings as of May 26, 2026. Publicly available information within the SEC context is limited to her board role; there is no readily accessible detailed biography within the provided context. There is no evidence in the available data that she has passed away as of the filing date.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live KAVANAGH SARAH B profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.